Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014338
Filing Date
2021-11-03
Accepted
2021-11-03 17:09:29
Documents
93
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20210930x10q.htm   iXBRL 10-Q 2188377
2 EX-10.1 ptgx-20210930xex10d1.htm EX-10.1 899184
3 EX-10.2 ptgx-20210930xex10d2.htm EX-10.2 67350
4 EX-10.3 ptgx-20210930xex10d3.htm EX-10.3 157271
5 EX-31.1 ptgx-20210930xex31d1.htm EX-31.1 10125
6 EX-31.2 ptgx-20210930xex31d2.htm EX-31.2 9951
7 EX-32.1 ptgx-20210930xex32d1.htm EX-32.1 9501
8 GRAPHIC ptgx-20210930x10q007.jpg GRAPHIC 34437
9 GRAPHIC ptgx-20210930xex10d3003.jpg GRAPHIC 2313
10 GRAPHIC ptgx-20210930xex10d3002.jpg GRAPHIC 2033
11 GRAPHIC ptgx-20210930xex10d3006.jpg GRAPHIC 80260
12 GRAPHIC ptgx-20210930xex10d3001.jpg GRAPHIC 1657
13 GRAPHIC ptgx-20210930xex10d3004.jpg GRAPHIC 25392
14 GRAPHIC ptgx-20210930xex10d3005.jpg GRAPHIC 1993
  Complete submission text file 0001558370-21-014338.txt   10317616

Data Files

Seq Description Document Type Size
15 EX-101.SCH ptgx-20210930.xsd EX-101.SCH 67672
16 EX-101.CAL ptgx-20210930_cal.xml EX-101.CAL 57375
17 EX-101.DEF ptgx-20210930_def.xml EX-101.DEF 227991
18 EX-101.LAB ptgx-20210930_lab.xml EX-101.LAB 529245
19 EX-101.PRE ptgx-20210930_pre.xml EX-101.PRE 432084
20 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20210930x10q_htm.xml XML 1591699
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 211376488
SIC: 2834 Pharmaceutical Preparations